Literature DB >> 9129284

Mastocytosis presenting as a skeletal disorder.

J L Delsignore1, P M Dvoretsky, D G Hicks, R J O'Keefe, R N Rosier.   

Abstract

Mastocytosis is a rare disease of mast-cell proliferation with involvement of the reticuloendothelial systems including skin, bone, gastrointestinal tract, liver, lungs, spleen, and lymph nodes. Systemic mastocytosis is characterized by a combination of symptoms that relate to the mast cells' release of vasoactive substances, such as histamine. These symptoms include urticaria pigmentosa, flushing, syncope with hypotension, headaches, nausea, vomiting, diarrhea, and occasional bronchospasm. The diagnosis of mastocytosis is typically based on the presence of the characteristic extraosseus manifestations. A well recognized roentgenographic feature seen in 70-75% of patients with mastocytosis is diffuse osteolysis and osteosclerosis, affecting primarily the axial skeleton and the ends of the long bones. Rarely, the bony involvement consists of generalized osteoporosis, which may lead to pathologic fracture, or solitary lesions (mastocytomas) which may cause symptoms of localized pain. Four patients with previously diagnosed systemic mastocytosis had unusual skeletal lesions. Clinical and laboratory evaluation of these patients eventually led to the correct diagnosis of systemic mastocytosis. We report these four cases to emphasize the need for thorough evaluation of unusual musculoskeletal findings in association with extraosseus symptoms that are characteristic of mastocytosis. Knowledge of a wide differential diagnosis of unusual skeletal lesions should include systemic mastosytosis.

Entities:  

Mesh:

Year:  1996        PMID: 9129284      PMCID: PMC2378151     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  31 in total

1.  Oral disodium cromoglycate in the treatment of systemic mastocytosis.

Authors:  N A Soter; K F Austen; S I Wasserman
Journal:  N Engl J Med       Date:  1979-08-30       Impact factor: 91.245

Review 2.  URTICARIA PIGMENTOSA WITH BONE INVOLVEMENT.

Authors:  W L BENDEL; G J RACE
Journal:  J Bone Joint Surg Am       Date:  1963-07       Impact factor: 5.284

3.  The presence of histamine in tissue mast cells.

Authors:  J F RILEY; G B WEST
Journal:  J Physiol       Date:  1953-06-29       Impact factor: 5.182

4.  Urticaria pigmentosa with bone lesions.

Authors:  G ASBOE-HANSEN
Journal:  Acta Derm Venereol       Date:  1953       Impact factor: 4.437

5.  Systemic mastocytosis. Extracutaneous manifestations.

Authors:  R D Brunning; R W McKenna; J Rosai; J L Parkin; R Risdall
Journal:  Am J Surg Pathol       Date:  1983-07       Impact factor: 6.394

6.  Systemic mastocytosis with review of gastrointestinal manifestations.

Authors:  R S Fishman; C R Fleming; C Y Li
Journal:  Mayo Clin Proc       Date:  1979-01       Impact factor: 7.616

7.  Systemic mastocytosis.

Authors:  P E Korenblat; H J Wedner; M P Whyte; S Frankel; L V Avioli
Journal:  Arch Intern Med       Date:  1984-11

8.  Mastocytosis with skeletal and gastrointestinal involvement in infancy. Two case reports and a review of the literature.

Authors:  J Lucaya; V Perez-Candela; C Aso; J Calvo
Journal:  Radiology       Date:  1979-05       Impact factor: 11.105

9.  Hazards in operative management of patients with systemic mastocytosis.

Authors:  H W Scott; W C Parris; P C Sandidge; J A Oates; L J Roberts
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

10.  Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks.

Authors:  L J Roberts; J W Turk; J A Oates
Journal:  Adv Shock Res       Date:  1982
View more
  12 in total

1.  Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man.

Authors:  Adam O Burzynski; Alfredo Luis Valente; Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2012-04-24       Impact factor: 4.176

2.  Impaired function of bone marrow stromal cells in systemic mastocytosis.

Authors:  Krisztian Nemeth; Todd M Wilson; Jiaqiang J Ren; Marianna Sabatino; David M Stroncek; Miklos Krepuska; Yun Bai; Pamela G Robey; Dean D Metcalfe; Eva Mezey
Journal:  Stem Cell Res       Date:  2015-05-08       Impact factor: 2.020

Review 3.  Benign spotted bones: a diagnostic dilemma.

Authors:  Gina Di Primio
Journal:  CMAJ       Date:  2011-01-17       Impact factor: 8.262

Review 4.  Sclerotic bone lesions caused by non-infectious and non-neoplastic diseases: a review of the imaging and clinicopathologic findings.

Authors:  Vaibhav Gulati; Majid Chalian; Jaehyuck Yi; Uma Thakur; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2020-10-11       Impact factor: 2.199

5.  Systemic mastocytosis with skeletal involvement: a case report and review of the literature.

Authors:  Maurizio Benucci; Catia Bettazzi; Stefania Bracci; Plinio Fabiani; Laura Monsacchi; Carlo Cappelletti; Mariangela Manfredi; Stefania Ciolli
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

6.  Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss.

Authors:  L A Fitzpatrick; E Buzas; T J Gagne; A Nagy; C Horvath; V Ferencz; A Mester; B Kari; M Ruan; A Falus; J Barsony
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

7.  Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.

Authors:  Peter Valent
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 8.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

Review 9.  European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.

Authors:  Peter Valent; Michel Arock; Patrizia Bonadonna; Knut Brockow; Sigurd Broesby-Olsen; Luis Escribano; Karoline V Gleixner; Clive Grattan; Emir Hadzijusufovic; Hans Hägglund; Olivier Hermine; Hans-Peter Horny; Hanneke C Kluin-Nelemans; Marcus Maurer; Marek Niedoszytko; Boguslaw Nedoszytko; Gunnar Nilsson; Hanneke N G Oude-Elberink; Alberto Orfao; Deepti Radia; Andreas Reiter; Frank Siebenhaar; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Jaap J VanDoormaal; Judit Várkonyi; Selim Yavuz; Karin Hartmann
Journal:  Wien Klin Wochenschr       Date:  2012-11-20       Impact factor: 1.704

10.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.